Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Chronic Liver Diseases Therapeutics Market In 2029?
In recent times, the market size for therapeutics for chronic liver diseases has seen a swift expansion. The market value is predicted to escalate from $14.38 billion in 2024 to $15.88 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.4%. The growth historically observed can be attributed to an increased prevalence of viral hepatitis, higher rates of obesity, aging population, heightened awareness about liver health, and improved patient accessibility to treatment options.
The market for therapeutics for chronic liver diseases is projected to witness a substantial rise in the coming years, reaching a valuation of$23.63 billion by 2029, expanding at a Compound Annual Growth Rate (CAGR) of 10.5%. The augmentation in the expected horizon is due to an intensified focus on individualized medicine, an escalating pipeline of innovative treatments, broader usage of telemedicine and digital health solutions, and increasing demand for prevention programs for liver diseases, along with growing incidents of viral hepatitis. Key trends involve the assimilation of artificial intelligence in diagnostics, the use of biologics and gene therapies, non-invasive treatment alternatives, combination therapies, and the broadening of patient-focused care models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21145&type=smp
Which Factors and External Forces Are Driving Demand in the Chronic Liver Diseases Therapeutics Market?
The rise in alcohol intake is anticipated to boost the chronic liver disease therapeutics market’s growth. Alcohol intake refers to the consumption of beverages containing ethanol and can vary from moderate to excessive use, potentially impacting health. The upsurge in alcohol intake could be attributed to growing societal acceptance, increasing income levels, and broader global accessibility. Chronic liver disease therapeutics aids in managing liver harm induced by excessive alcohol consumption by reducing disease progression and enhancing liver functionality. The First Citizens Bank, a financial institution based in the United States, reported a 1.2% increase in direct-to-consumer (DTC) wine case sales in 2023 compared to 2022. Furthermore, according to a report released by Kirin Holdings Company Limited, a beverage company based in Japan, there was a 2.9% increase from the previous year, with about 192.1 million kiloliters of beer consumed in 2022. Consequently, the rise in alcohol intake is fueling the growth of the chronic liver disease therapeutics market.
Which Segments in the Chronic Liver Diseases Therapeutics Offer the Most Growth?
The chronic liver diseases therapeuticsmarket covered in this report is segmented –
1) By Treatment Type: Antiviral Drugs; Immunosuppressants Vaccines; Immunoglobulins; Corticosteroids; Targeted Therapy; Chemotherapy
2) By Disease Type: Hepatitis; Autoimmune Diseases; Non-Alcoholic Fatty Liver Disease; Cancer; Genetic Disorders
3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Antiviral Drugs: Nucleoside Or Nucleotide Analogues; Interferons; Direct-Acting Antivirals
2) By Immunosuppressants: Calcineurin Inhibitors; mTOR Inhibitors; Purine Synthesis Inhibitors
3) By Vaccines: Hepatitis A Vaccine; Hepatitis B Vaccine; Combination Hepatitis Vaccines
4) By Immunoglobulins: Hepatitis B Immune Globulin; Intravenous Immunoglobulin
5) By Corticosteroids: Prednisolone; Methylprednisolone; Dexamethasone
6) By Targeted Therapy: Tyrosine Kinase Inhibitors; Monoclonal Antibodies
7) By Chemotherapy: Systemic Chemotherapy; Transarterial Chemoembolization Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21145&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Chronic Liver Diseases Therapeutics Market?# Market?
North America was the largest region in the chronic liver diseases therapeutics market in 2024. The regions covered in the chronic liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theChronic Liver Diseases Therapeutics Market’s Growth?
Predominant corporations in the therapeutics market for chronic liver diseases are making strides in creating groundbreaking innovations like RNA therapies, aimed at the core genetic and molecular intricacies, thereby offering more efficient and tailored treatment alternatives. RNA therapies are progressive medical interventions that utilize RNA molecules in the regulation of gene expression or protein synthesis, with a goal to cure or avert diseases by focusing on particular genetic mechanisms. For example, Ochre Bio, a biotech firm based in the UK, unveiled its revolutionary ‘Liver ICU’ research facility at BioLabs@NYULangone, a biopharma incubator located in New York City, in May 2022. This modern site scrutinizes the efficacy of next-generation RNA therapeutics by using whole human livers kept alive on perfusion machines. With the objective of hastening drug development processes and enhancing the accuracy of liver treatment studies by reproducing human physiological conditions, the facility employs discarded donor livers for research purposes.
View the full report here:
What Are the Key Elements That Define the Chronic Liver Diseases Therapeutics Market?
Chronic liver disease therapeutics refers to the medical treatments and interventions aimed at managing long-term liver conditions. These therapies focus on slowing disease progression, alleviating symptoms, and improving liver function through medications, lifestyle changes, and, in some cases, advanced procedures.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21145
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model